Skip to main content
BMC Proceedings logoLink to BMC Proceedings
. 2011 Jan 10;5(Suppl 1):P23.

A transgenic mouse model for studying HBV infection in neonate

Zhuo Wang 1,, Qiang Deng 1, Ke Lan 1
PMCID: PMC3019447

The human hepatitis B virus (HBV) infection is always a worldwide problem, especially the high risk infection of the neonate by chronically HBV infected mother. McGrane et al. [1] have demonstrated that the gene which is driven by the promoter of phosphoenolpyruvate carboxykinase (PEPCK) is mainly expressed in the mouse liver and immediately appears at parturition. We have constructed a transgenic mouse by using PEPCK promoter to drive the pre-S2 and S domain of HBV envelope protein to imitate HBV transmission from mother to child. We want to see whether hepatitis B surface antigen (HBsAg) can persistently exist or be cleared by immune system from the newborn mice.

Contributor Information

Qiang Deng, Email: dengqiang@sibs.ac.cn.

Ke Lan, Email: lanke@sibs.ac.cn.

References

  1. McGrane MM, Yun JS, Moorman AF. et al. Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J Biol Chem. 1990;265:22371–22379. [PubMed] [Google Scholar]

Articles from BMC Proceedings are provided here courtesy of BMC

RESOURCES